CD81 and acute myeloid leukemia: However, as we did not find any difference between patients with CD81+ vs. CD81− AML in achieving complete remission (CR) after remission induction therapy, the mechanism may be less likely to be chemotherapy resistance induced by CD81 expression on leukemic blasts.